These findings suggest that [177Lu]Lu-DOTA-CCK2R-dimer may alleviate the oxidative stress burden in tumor cells by activating radiotherapy-related detoxification pathways, whereas the addition of an mTOR inhibitor may increase therapeutic efficacy by suppressing these pathways, thus increasing the susceptibility of tumor cells to oxidative damage. Here, CCKBR is linked to neoplasm.